Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO1 | P15559 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | LTA4H | P09960 | 2/20 | 0.44 |
| ▸ | MAOB | P27338 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.43 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | PLK1 | P53350 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | KIF11 | P52732 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23512941 | 0.85 | NQO1 (0.52) | NQO1TSHRTDP1ALDH1A1LTA4H | |
| SCHEMBL805161 | 0.83 | NQO1 (0.61) | NQO1TSHRTDP1MAOBMAPT | |
| SCHEMBL18911100 | 0.82 | NQO1 (0.54) | NQO1TSHRTDP1ATMALDH1A1 | |
| SCHEMBL13902305 | 0.82 | CYP3A4 (0.68) | ALDH1A1MAOBCYP3A4SMN1; SMN2CYP1A1 | |
| SCHEMBL23475051 | 0.82 | SMN1; SMN2 (0.57) | LTA4HMAOBCYP3A4SMN1; SMN2MAPT | |
| SCHEMBL11128383 | 0.82 | NQO1 (0.58) | NQO1TSHRTDP1ATMALDH1A1 | |
| SCHEMBL6810964 | 0.82 | ALDH1A1 (0.51) | TDP1ALDH1A1EPHX2NR1H4MAPT | |
| SCHEMBL10549168 | 0.80 | NQO1 (0.47) | NQO1TSHRTDP1ALDH1A1MAOB | |
| SCHEMBL1257955 | 0.80 | SMN1; SMN2 (0.66) | NQO1TSHRTDP1ALDH1A1LTA4H | |
| SCHEMBL8509041 | 0.80 | NQO1 (0.56) | NQO1TSHRTDP1ATMLTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250281926-A1 | SAMPLE MANIPULATION AND ASSAY WITH RAPID TEMPERATURE CHANGE | ESSENLIX CORPORATION (US) | 2025-09-11 | — | — | US | disclosed |
| US-12270810-B2 | QMAX assay and applications (II) | ESSENLIX CORPORATION (US) | 2025-04-08 | — | — | US | disclosed |
| US-12226769-B2 | Sample manipulation and assay with rapid temperature change | ESSENLIX CORPORATION (US) | 2025-02-18 | — | — | US | disclosed |
| US-12064771-B2 | Rapid sample temperature changing for assaying | ESSENLIX CORPORATION (US) | 2024-08-20 | — | — | US | disclosed |
| US-11796428-B2 | Compressed open flow assay and use | ESSENLIX CORPORATION (US) | 2023-10-24 | — | — | US | disclosed |
| CN-110770572-B | Colorimetric assay | ESSENLIX公司 | 2023-08-18 | — | — | CN | disclosed |
| US-11712177-B2 | Assay with textured surface | ESSENLIX CORPORATION (US) | 2023-08-01 | — | — | US | disclosed |
| US-11648551-B2 | Sample manipulation and assay with rapid temperature change | ESSENLIX CORPORATION (US) | 2023-05-16 | — | — | US | disclosed |
| US-11604148-B2 | Colorimetric assays | ESSENLIX CORPORATION (US) | 2023-03-14 | — | — | US | disclosed |
| US-20230013771-A1 | Method of Detecting an Analyte in a Sample | ESSENLIX CORP. | 2023-01-19 | — | — | US | disclosed |
| US-20220236149-A1 | COMPRESSED OPEN FLOW ASSAY AND USE | ESSENLIX CORPORATION (US) | 2022-07-28 | — | — | US | disclosed |
| US-11274996-B2 | Compressed open flow assay and use | ESSENLIX CORPORATION (US) | 2022-03-15 | — | — | US | disclosed |
| US-20170231999-A1 | IDO INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2017-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170231999-A1 | IDO INHIBITORS | IDO1, IDO2, INMT | NQO1 30/4885TSHR 4369/4885TDP1 1022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.